Locally Advanced Triple Negative Breast Cancer clinical trials

Explore recruiting locally advanced triple negative breast cancer clinical trials.

Recruiting locally advanced triple negative breast cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Locally Advanced Triple Negative Breast Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ALTER : A Phase 2, Multicenter, Randomized, Open-label trial assessing sacituzumab-govitecan and trastuzumab-deruxtecan combinaison in an ALTERnating regimen for patients with metastatic or locally advanced Her2-low triple-negative breast Cancer

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Locally Advanced Triple Negative Breast Cancer trials by city

Locally Advanced Triple Negative Breast Cancer in Toronto Locally Advanced Triple Negative Breast Cancer in Vancouver Locally Advanced Triple Negative Breast Cancer in Montreal Locally Advanced Triple Negative Breast Cancer in Calgary Locally Advanced Triple Negative Breast Cancer in Edmonton Locally Advanced Triple Negative Breast Cancer in Ottawa Locally Advanced Triple Negative Breast Cancer in Winnipeg Locally Advanced Triple Negative Breast Cancer in Quebec City Locally Advanced Triple Negative Breast Cancer in Hamilton Locally Advanced Triple Negative Breast Cancer in Kitchener Locally Advanced Triple Negative Breast Cancer in London Locally Advanced Triple Negative Breast Cancer in Halifax Locally Advanced Triple Negative Breast Cancer in New York Locally Advanced Triple Negative Breast Cancer in Los Angeles Locally Advanced Triple Negative Breast Cancer in Chicago Locally Advanced Triple Negative Breast Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease